How effective are vaccines against Delta variant? Reports vary as immunized patient dies in Calgary hospital
As confirmed cases of the Delta variant of COVID-19 continue to rise in Alberta, there are conflicting statements regarding how effective the first dose of vaccine is at protecting against severe outcomes of infection.
Alberta Health Services confirms a patient in their 80s, who had received two doses of MRNA vaccine before contracting the Delta variant, died in an outbreak at the Foothills Medical Centre in Calgary. A second unvaccinated patient, who was also over the age of 80, also died in the outbreak.
The outbreak at the hospital in northwest Calgary now spans two units with confirmed cases in 21 patients and nine staff members.
In response to those outbreaks, AHS says vaccines were given to those in hospital at risk of exposure to the Delta variant — also known as B.1.617.2, that was first identified in India.
Earlier this month, AHS officials told CTV news a first dose of an MRNA vaccine such as Pfizer or Moderna offers 33 per cent protection against the Delta variant with a single dose and coverage increased to 88 per cent with a second dose.
Yet, on Monday, Premier Jason Kenney tweeted a report from the United Kingdom — where cases of the Delta variant are rising —indicating one dose of Pfizer vaccine is 94 per cent effective against hospitalizations involving the Delta variant and increases to 96 per cent after a second dose.
Alberta confirmed its first case of this variant of concern on April 8.
According to the latest data, it has spread to 356 confirmed cases, with more than 300 in the Calgary health zone.
University of Calgary biologist and member of the 'COVID-19 to Zero' advocacy group Gosia Gasperowicz says the exponential growth of this variant could potentially result in as many as 2,000 daily new cases in Alberta by early August.
CTVNews.ca Top Stories
NEW From yearning for a change to cost of living, why some Canadians have left or may leave the country
For some immigrants, their dreams of permanently settling in Canada have taken an unexpected twist.
NEW Capital gains tax change 'shortsighted' and 'sows division' business groups tell Freeland
Forging ahead with increasing Canada's capital gains inclusion rate 'sows division,' and is a 'shortsighted' way to improve the deficit, business groups are warning Finance Minister Chrystia Freeland.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Canucks claw out 5-4 comeback win over Oilers in Game 1
Dakota Joshua had a goal and two assists and the Vancouver Canucks scored three third-period goals to claw out a 5-4 comeback victory over the Edmonton Oilers in Game 1 of their second-round playoff series Wednesday.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.
Florida deputies who fatally shot U.S. airman burst into wrong apartment, attorney says
Deputies responding to a disturbance call at a Florida apartment complex burst into the wrong unit and fatally shot a Black U.S. Air Force airman who was home alone when they saw he was armed with a gun, an attorney for the man's family said Wednesday.
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
Nijjar murder suspect says he had Canadian study permit in immigration firm's video
One of the Indian nationals accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar says in a social media video that he received a Canadian study permit with the help of an Indian immigration consultancy.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.